SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-23-035144
Filing Date
2023-03-21
Accepted
2023-03-21 17:07:23
Documents
5
Effectiveness Date
2023-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2310053d9_s8pos.htm S-8 POS 55677
2 EXHIBIT 5.1 tm2310053d9_ex5-1.htm EX-5.1 11912
3 EXHIBIT 23-2 tm2310053d9_ex23-2.htm EX-23.2 1956
4 GRAPHIC tm2310053d9_ex5-1img01.jpg GRAPHIC 2641
5 GRAPHIC tm2310053d9_ex5-1img02.jpg GRAPHIC 73307
  Complete submission text file 0001104659-23-035144.txt   176589
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc (DE) (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-258819 | Film No.: 23750395
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-258819-01 | Film No.: 23750396
SIC: 2834 Pharmaceutical Preparations